Victoria P. Werth

1979–2025 年に発表

176
論文数
24,129
被引用数
81
h 指数
162
i10 指数

被引用数

Victoria P. Werth の年別被引用数1984 年: 被引用 2 件1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 4 件1999 年: 被引用 4 件2000 年: 被引用 2 件2001 年: 被引用 2 件2002 年: 被引用 19 件2003 年: 被引用 19 件2004 年: 被引用 20 件2005 年: 被引用 33 件2006 年: 被引用 12 件2007 年: 被引用 25 件2008 年: 被引用 17 件2009 年: 被引用 46 件2010 年: 被引用 26 件2011 年: 被引用 72 件2012 年: 被引用 46 件2013 年: 被引用 69 件2014 年: 被引用 88 件2015 年: 被引用 90 件2016 年: 被引用 116 件2017 年: 被引用 140 件2018 年: 被引用 199 件2019 年: 被引用 876 件2020 年: 被引用 870 件2021 年: 被引用 856 件2022 年: 被引用 835 件2023 年: 被引用 594 件2024 年: 被引用 1,131 件2025 年: 被引用 593 件2026 年: 被引用 10 件1985〜1987 年は被引用が無いため表示していません1991〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,677 件、この内訳の 20.3%中国: 引用元論文 674 件、この内訳の 8.1%ドイツ: 引用元論文 491 件、この内訳の 5.9%イタリア: 引用元論文 478 件、この内訳の 5.8%イギリス: 引用元論文 474 件、この内訳の 5.7%フランス: 引用元論文 393 件、この内訳の 4.8%日本: 引用元論文 317 件、この内訳の 3.8%カナダ: 引用元論文 268 件、この内訳の 3.2%スウェーデン: 引用元論文 267 件、この内訳の 3.2%オーストラリア: 引用元論文 245 件、この内訳の 3%スペイン: 引用元論文 239 件、この内訳の 2.9%オランダ: 引用元論文 214 件、この内訳の 2.6%
0%20.3%その他 30.7%

分野

  • Medicine82.7%
  • Immunology and Microbiology9.3%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Neuroscience0.4%
  • Dentistry0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • その他1.9%

トピック

  • Systemic Lupus Erythematosus Research14.1%
  • Inflammatory Myopathies and Dermatomyositis5.7%
  • Rheumatoid Arthritis Research and Therapies4.4%
  • Autoimmune Bullous Skin Diseases3.7%
  • T-cell and B-cell Immunology3.7%
  • Systemic Sclerosis and Related Diseases3.6%
  • その他64.8%

共著者

全論文

検索で開く
  1. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Anne Dooley, Ronald van Vollenhoven, Ellen M. Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffrey P. Callen, S. Sam Lim, Barri J. Fessler, Murat İnanç, Diane L. Kamen, Anisur Rahman, Kristján Steinsson, Andrew G. Franks, Lisa Sigler, Suhail Hameed, Hong Fang, Ngoc Minh Pham, Robin L. Brey, Michael H. Weisman, Gerald McGwin, Laurence S. Magder - Arthritis & Rheumatism 2012 被引用: 5,295

  2. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helga Sanner, Albert Selva-O’Callaghan, Yeong‐Wook Song, Jiří Vencovský, Steven R. Ytterberg, Frederick W. Miller, Lisa G. Rider - Annals of the Rheumatic Diseases 2017 被引用: 1,525

  3. 2021 DORIS definition of remission in SLE: final recommendations from an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Faria, Rebecca S. B. Fischer, Ruth Fritsch‐Stork, Murat İnanç, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Olesińska, Guillermo Pons‐Estel, Juanita Romero‐Díaz, Blanca Rubio, Y Schoenfeld, Eloísa Bonfá, Josef S Smolen, Y K Onno Teng, Anǵela Tincani, Michel Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharhova, Cynthia Aranow - Lupus Science & Medicine 2021 被引用: 349

  4. Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus

    著者: , , , , , , , , , , - Arthritis & Rheumatology 2016 被引用: 867

  5. Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

    著者: , , , , , , , , , , , , - Arthritis & Rheumatology 2022 被引用: 248

  6. Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 129

  7. Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Frontiers in Medicine 2022 被引用: 150

  8. 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuromuscular Disorders 2019 被引用: 299

  9. Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 137

  10. Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study

    著者: , , , , , , , , - Annals of the Rheumatic Diseases 2016 被引用: 498

  11. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 被引用: 297

  12. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Véronique Le Guern, Kirsten Lerstrøm, Roger A. Levy, Francinne Machado-Ribeiro, Xavier Mariette, Jamil Missaykeh, Eric F. Morand, Marta Mosca, Murat İnanç, Sandra Navarra, Irmgard Neumann, Marzena Olesińska, Michelle Petri, Anisur Rahman, Ole Petter Rekvig, Jozef Rovenský, Yehuda Shoenfeld, Josef S Smolen, Anǵela Tincani, Murray B. Urowitz, Bernadette van Leeuw, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharova, Asad Zoma, Matthias Schneider, Michael M. Ward - Annals of the Rheumatic Diseases 2016 被引用: 357

  13. Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

    著者: , , , , , , , , , , , , , - The Lancet 2018 被引用: 324

  14. The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent

    著者: , , , , , , , , , , , , - Scientific Reports 2020 被引用: 115

  15. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mazen M. Dimachkie, Erik Ensrud, Floranne C. Ernste, D. Gareth Evans, Manabu Fujimoto, Ignacio García‐De La Torre, Abraham García-Kutzbach, Zoltán Griger, Latika Gupta, Marie Hudson, Florenzo Iannone, David Isenberg, Joseph L. Jorizzo, Helen Kurtz, Masataka Kuwana, Vidya Limaye, Ingrid E. Lundberg, Andrew L. Mammen, H. Mann, Frank Mastaglia, Lorna McWilliams, Christopher A. Mecoli, Federica Meloni, Frederick W. Miller, Siamak Moghadam‐Kia, Sergey Moiseev, Yoshinao Muro, Melinda Nagy‐Vincze, Clive Nayler, Merrilee Needham, Ichizo Nishino, Chester V. Oddis, Julie J. Paik, Joost Raaphorst, Lisa G. Rider, Jorge Rojas‐Serrano, Lesley Ann Saketkoo, Adam Schiffenbauer, Samuel Katsuyuki Shinjo, Vineeta Shobha, Yeong‐Wook Song, Tania Tillett, Yves Troyanov, Anneke J. van der Kooi, Mónica Vázquez-Del Mercado, Jiří Vencovský, Qian Wang, Steven R. Ytterberg, Rohit Aggarwal - Nature Reviews Rheumatology 2023 被引用: 139

  16. Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Terrelonge - Science Translational Medicine 2021 被引用: 117

  17. Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 107

  18. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus

    著者: , , , , , , , , , , , , , , - Journal of Investigative Dermatology 2005 被引用: 502

  19. Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris

    著者: , , , , , , , , , - New England Journal of Medicine 2021 被引用: 112

  20. Classification of myositis

    著者: , , - Nature Reviews Rheumatology 2018 被引用: 312

  21. American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity

    著者: , , , , , , , , , , - Arthritis & Rheumatology 2021 被引用: 121

  22. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist

    著者: , , - The Journal of Rheumatology 2022 被引用: 99

  23. Diagnosis and management of pemphigus: Recommendations of an international panel of experts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ron J. Feldman, Adela R. Cardones, Johann Bauer, D. Ioannides, Hana Jedličková, Francis Palisson, Aikaterini Patsatsi, Soner Uzun, Savaş Yaylı, Detlef Zillikens, Masayuki Amagai, Michael Hertl, Enno Schmidt, Valéria Aoki, Sergei A. Grando, Hiroshi Shimizu, Sharon Baum, Guiseppe Cianchini, Claudio Feliciani, Pilar Iranzo, José M. Mascaró, Cezary Kowaléwski, Russell P. Hall, Richard Groves, Karen Harman, M. Peter Marinkovich, Emanual Maverakis, Victoria P. Werth - Journal of the American Academy of Dermatology 2018 被引用: 373

  24. Nuclear envelope rupture and NET formation is driven by PKCα‐mediated lamin B disassembly

    著者: , , , , , - EMBO Reports 2020 被引用: 100